- Home
- QNCX vs VNRX Comparison
QNCX vs VNRX Comparison
Compare QNCX & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNCX
- VNRX
- Stock Information
- Founded
- QNCX 2012
- VNRX N/A
- Country
- QNCX United States
- VNRX United States
- Employees
- QNCX N/A
- VNRX N/A
- Industry
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- QNCX Health Care
- VNRX Health Care
- Exchange
- QNCX Nasdaq
- VNRX Nasdaq
- Market Cap
- QNCX 44.0M
- VNRX 45.2M
- IPO Year
- QNCX 2019
- VNRX N/A
- Fundamental
- Price
- QNCX $1.02
- VNRX $0.52
- Analyst Decision
- QNCX Strong Buy
- VNRX Strong Buy
- Analyst Count
- QNCX 5
- VNRX 5
- Target Price
- QNCX $8.00
- VNRX $3.75
- AVG Volume (30 Days)
- QNCX 511.8K
- VNRX 172.1K
- Earning Date
- QNCX 05-16-2025
- VNRX 05-20-2025
- Dividend Yield
- QNCX N/A
- VNRX N/A
- EPS Growth
- QNCX N/A
- VNRX N/A
- EPS
- QNCX N/A
- VNRX N/A
- Revenue
- QNCX N/A
- VNRX $1,233,511.00
- Revenue This Year
- QNCX N/A
- VNRX $563.72
- Revenue Next Year
- QNCX N/A
- VNRX $160.43
- P/E Ratio
- QNCX N/A
- VNRX N/A
- Revenue Growth
- QNCX N/A
- VNRX 59.10
- 52 Week Low
- QNCX $0.51
- VNRX $0.42
- 52 Week High
- QNCX $2.45
- VNRX $0.90
- Technical
- Relative Strength Index (RSI)
- QNCX 38.15
- VNRX 52.65
- Support Level
- QNCX $0.98
- VNRX $0.46
- Resistance Level
- QNCX $1.16
- VNRX $0.54
- Average True Range (ATR)
- QNCX 0.09
- VNRX 0.04
- MACD
- QNCX 0.00
- VNRX 0.01
- Stochastic Oscillator
- QNCX 20.04
- VNRX 67.50
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.